Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits.

The Journal of neuroscience : the official journal of the Society for Neuroscience | 2009

The loss of Fragile X mental retardation protein (FMRP) causes Fragile X syndrome, the most common inherited mental retardation and single gene cause of autism. Although postsynaptic functions for FMRP are well established, potential roles at the presynaptic apparatus remain largely unexplored. Here, we characterize the expression of FMRP and its homologs, FXR1P and FXR2P, in the developing, mature and regenerating rodent nervous system, with a focus on presynaptic expression. As expected, FMRP is expressed in the somatodendritic domain in virtually all neurons. However, FMRP is also localized in discrete granules (Fragile X granules; FXGs) in a subset of brain regions including frontal cortex, hippocampal area CA3 and olfactory bulb glomeruli. Immunoelectron microscopy shows that FMRP is localized at presynaptic terminals and in axons within these FXG-rich regions. With the exception of the olfactory bulb, FXGs are prominent only in the developing brain. Experiments in regenerating olfactory circuits indicate that peak FXG expression occurs 2-4 weeks after neurogenesis, a period that correlates with synapse formation and refinement. Virtually all FXGs contain FXR2P, while region-selective subsets harbor FMRP and/or FXR1P. Genetic studies show that FXR2P is essential for FXG expression, while FMRP regulates FXG number and developmental profile. These findings suggest that Fragile X proteins play a distinct, presynaptic role during discrete developmental epochs in defined circuits of the mammalian CNS. We propose that the neurological defects in Fragile X syndrome, including the autistic features, could be due in part to the loss of FMRP function in presynaptic compartments.

Pubmed ID: 19193898 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Associated grants

  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC002167-10
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578-030002
  • Agency: NIDCD NIH HHS, United States
    Id: DC002167
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC002167
  • Agency: NICHD NIH HHS, United States
    Id: HD052083
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC002167-13
  • Agency: NIDA NIH HHS, United States
    Id: DA021501
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578-03S10002
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578-050002
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC002167-12
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD052083-03
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD052083-01
  • Agency: NIDA NIH HHS, United States
    Id: F32 DA021501-02
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578-010002
  • Agency: NINDS NIH HHS, United States
    Id: P01 NS039321-05
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578-01S10002
  • Agency: NIA NIH HHS, United States
    Id: T32 AG020498-02
  • Agency: NINDS NIH HHS, United States
    Id: P01 NS039321-02
  • Agency: NIA NIH HHS, United States
    Id: T32 AG020498-01A1
  • Agency: NINDS NIH HHS, United States
    Id: P01 NS039321-04
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578-060002
  • Agency: NINDS NIH HHS, United States
    Id: P01 NS039321-01
  • Agency: NIA NIH HHS, United States
    Id: T32 AG020498-03
  • Agency: NINDS NIH HHS, United States
    Id: P01 NS039321
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578-040002
  • Agency: NIA NIH HHS, United States
    Id: AG02049
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC002167-14
  • Agency: NIDA NIH HHS, United States
    Id: F32 DA021501
  • Agency: NINDS NIH HHS, United States
    Id: P01 NS039321-03
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD052083
  • Agency: NCRR NIH HHS, United States
    Id: P20 RR015578-020002
  • Agency: NICHD NIH HHS, United States
    Id: R01 HD052083-02
  • Agency: NIDCD NIH HHS, United States
    Id: R01 DC002167-11
  • Agency: NIDA NIH HHS, United States
    Id: F32 DA021501-01A1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.